title: Efficacy of standard triple therapy in the treatment of Helicobacter pylori infection: experience from Kuwait.
abstract: BACKGROUND
  Recent studies suggest that the initial treatment success rates for H. pylori infection are falling below 80% in many parts of the world.
  
  
  OBJECTIVE
  The aim of this study was to evaluate the efficacy of standard triple therapy in the treatment of H. pylori infection in Kuwait.
  
  
  METHODS
  Consecutive H. pylori positive patients were enrolled in the study to receive clarithromycin, amoxicillin and omeprazole for 10 days. H. pylori status was checked with 13C urea breath test 6 weeks after the end of therapy. Endoscopic findings was recorded in all patients.
  
  
  RESULTS
  One hundred forty-one patients (82 male and 59 females; mean age 41.8 years) were enrolled in the study. A total of seven patients were excluded from the per protocol analysis. The eradication rates in intention to treat (ITT) and per protocol (PP) were 72.3% (95% CI 64.2-79.5%) and 76.1% (95% CI 68-83%), respectively. The main endoscopic findings were normal in 47.5% and gastritis in 37.6%.
  
  
  CONCLUSIONS
  The efficacy of the current standard triple therapy for H. pylori eradication in our community is suboptimal. Confirmation for H. pylori eradication with noninvasive tests is recommended, especially in high-risk patients. New antimicrobial regimens for H. pylori eradication are considered necessary.
authors.affiliation: Thunayan Alghanim Center of Gastroenterology, Amiri Hospital, Kuwait City, Kuwait. waleed@hsc.edu.kw
authors.forename: Waleed M
authors.initials: WM
authors.lastname: Alazmi
authors.forename: Waleed
authors.initials: W
authors.lastname: Buhaimed
authors.forename: Khalid
authors.initials: K
authors.lastname: Al-Mekhaizeem
authors.forename: Iqbal
authors.initials: I
authors.lastname: Siddique
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D016099:Endoscopy, Gastrointestinal; D005260:Female; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D007730:Kuwait; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole